Displaying credibility toward 2027

B2

MEDIUM RISK for enterprise

  • Economic risk

  • Business environment risk

  • Political risk

  • Commercial risk

  • Financing risk

  • Economic risk

  • Business environment risk

  • Political risk

  • Commercial risk

  • Financing risk

Updated in December 2024.

Swipe to view more

Form of state Parliamentary Republic
Head of state Aleksandar Vučić (President)
Next elections 2027, presidential and legislative
  • Collaboration with the IMF and adherence to fiscal deficit targets are ensuring a steady decline in public debt, projected to reach 45% of GDP by 2025.
  • Robust growth, supported by strong private consumption and FDI inflows.
  • Ambitious infrastructure projects and energy diversification, including EXPO 2027, lithium mining and nuclear collaboration, position Serbia for sustainable long-term growth.

 

  • Tensions with Kosovo and balancing EU accession with ties to Russia and China complicate foreign relations, attracting criticism and potential diplomatic fallout.
  • A widening current account deficit and reliance on import-driven infrastructure spending pose risks to macroeconomic stability.
  • Persistent issues with regulatory quality, local governance and environmental management hinder investor confidence and sustainable progress.
(% of total, 2023)
(% of total, annual 2023)

Trade structure by destination/origin

(% of total, 2022)

Exports Rank Imports
Germany 13.7%
1
12.1% China
Bosnia and Herzegovina 7.5%
2
11.4% Germany
Italy 7.2%
3
7.5% Russian Federation
Hungary 5.4%
4
6.6% Italy
Romania 4.4%
5
5.6% Hungary

Trade structure by product

(% of total, 2022)

Exports Rank Imports
Electrical machinery, apparatus and appliances, n.e.s. 11.0%
1
7.7% Petroleum, petroleum products and related materials
Metalliferous ores and metal scrap 7.0%
2
5.7% Electrical machinery, apparatus and appliances, n.e.s.
Power generating machinery and equipment 5.0%
3
4.4% Gas, natural and manufactured
Iron and steel 4.4%
4
4.1% Electric current
Vegetables and fruits 4.2%
5
3.9% Medicinal and pharmaceutical products